Galmed Pharmaceuticals Ltd.
GLMD
$1.07
$0.1111.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.57% | -48.26% | -15.56% | -8.75% | 16.07% |
| Total Depreciation and Amortization | -100.00% | -100.00% | 131.25% | 167.74% | 161.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 392.40% | 270.62% | 255.72% | 262.91% | -43.93% |
| Change in Net Operating Assets | -119.37% | 167.42% | 72.55% | -651.52% | 131.83% |
| Cash from Operations | -30.16% | 6.64% | 15.85% | 3.19% | 47.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -330.91% | -1,655.46% | -2,315.13% | -376.38% | 621.96% |
| Cash from Investing | -330.91% | -1,655.46% | -2,315.13% | -376.38% | 623.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -0.62% | 164.11% | 66.53% | 42.05% | 34.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -0.62% | 164.11% | 66.53% | 42.05% | 34.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -190.40% | 137.18% | 1,142.72% | -25.24% | 374.83% |